Related Experiment Video
Updated: Jul 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Editorial summary of symposium on hypertensive disorders of pregnancy
Insights
Hypertensive disorders of pregnancy, including preeclampsia, are a major cause of maternal and neonatal death. Effective management involves aggressive hypertension treatment, magnesium sulfate for seizures, and expert care to improve outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Critical Care in Pregnancy
Background:
- Hypertensive disorders of pregnancy, notably preeclampsia/eclampsia, are primary drivers of global maternal and neonatal mortality.
- These complex conditions present significant diagnostic and therapeutic challenges for healthcare providers worldwide.
Discussion:
- Clinical management strategies vary, with expert opinions highlighting aggressive hypertension control and magnesium sulfate for seizure prevention as crucial.
- Risk assessment, vigilant antenatal surveillance, and timely delivery are emphasized for improved maternal and fetal well-being.
- The evidence for preventative measures like aspirin, calcium, and vitamins C and E remains debated, necessitating further research.
Key Insights:
- Aggressive treatment of severe hypertension and seizure prophylaxis with magnesium sulfate are proven to enhance maternal and neonatal outcomes.
- Management by experienced healthcare professionals is critical for mitigating risks associated with hypertensive disorders of pregnancy.
- A new classification paradigm and evidence-based interventions are being developed to refine the approach to these conditions.
Outlook:
- Further well-designed studies are essential for advancing evidence-based care for mothers and newborns globally.
- Continued research into the pathophysiology and management of hypertensive disorders of pregnancy will drive improvements in clinical practice.
- International collaboration and sharing of expertise are vital for addressing the global burden of these conditions.
Purpose Of Review:
Hypertensive disorders of pregnancy, particularly the preeclampsia/eclampsia syndrome, remain the leading causes of worldwide pregnancy-related maternal and neonatal mortality and morbidity. This group of conditions are a 'riddle wrapped in a mystery inside an enigma' to quote Winston Churchill. We are fortunate to have contributions from leading clinical experts who have devoted many years of their professional careers attempting to solve this conundrum.
Recent Findings:
Dr Jack Moodley has provided us with a perspective on clinical management in underresourced countries. Referral to experts, aggressive treatment of hypertension and use of magnesium sulfate improves care. Dr Shennan focuses on the assessment of risk, close antenatal surveillance and timely delivery. Dr Uzan continues to champion the use of aspirin for prevention of preeclampsia, even though the evidence is contradictory. Dr Sibai addresses the lack of evidence for calcium, vitamin C and E in prevention of preeclampsia. Dr Von Dadelszen is developing a new paradigm for the classification of these disorders and emphasizes the importance of evidence-based intervention.
Summary:
Evidence suggests that treatment of severe hypertension, seizure prophylaxis with magnesium sulfate, and management by experienced healthcare professionals will improve maternal, fetal and neonatal outcomes. Well designed studies will lead to evidence-based improvement in caring for mothers and babies worldwide.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hormonal Regulation